Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Renal relapse in antineutrophil cytoplasmic autoantibody-associated vasculitis: unpredictable, but predictive of renal outcome.

Wester Trejo MAC, Floßmann O, Westman KW, Höglund P, Hagen EC, Walsh M, Bruijn JA, Jayne DRW, Bajema IM, Berden AE.

Rheumatology (Oxford). 2019 Jan 1;58(1):103-109. doi: 10.1093/rheumatology/key260.

PMID:
30551161
2.

Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts.

Yates M, Watts R, Bajema I, Cid M, Crestani B, Hauser T, Hellmich B, Holle J, Laudien M, Little MA, Luqmani RA, Mahr A, Merkel P, Mills J, Mooney J, Segelmark M, Tesar V, Westman KWA, Vaglio A, Yalçındağ N, Jayne DR, Mukhtyar C.

RMD Open. 2017 Jun 15;3(1):e000449. doi: 10.1136/rmdopen-2017-000449. eCollection 2017.

3.

ANCA-Associated Glomerulonephritis: Risk Factors for Renal Relapse.

Göçeroğlu A, Berden AE, Fiocco M, Floßmann O, Westman KW, Ferrario F, Gaskin G, Pusey CD, Hagen EC, Noël LH, Rasmussen N, Waldherr R, Walsh M, Bruijn JA, Jayne DR, Bajema IM; European Vasculitis Society (EUVAS).

PLoS One. 2016 Dec 14;11(12):e0165402. doi: 10.1371/journal.pone.0165402. eCollection 2016.

4.

Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa.

Mohammad AJ, Jacobsson LT, Westman KW, Sturfelt G, Segelmark M.

Rheumatology (Oxford). 2009 Dec;48(12):1560-5. doi: 10.1093/rheumatology/kep304. Epub 2009 Oct 1.

PMID:
19797309
5.

Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis.

Jayne DR, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L, Mirapeix E, Savage CO, Sinico RA, Stegeman CA, Westman KW, van der Woude FJ, de Lind van Wijngaarden RA, Pusey CD; European Vasculitis Study Group.

J Am Soc Nephrol. 2007 Jul;18(7):2180-8. Epub 2007 Jun 20.

6.
8.

C3 and C4 allotypes in anti-neutrophil cytoplasmic autoantibody (ANCA)-positive vasculitis.

Persson U, Truedsson L, Westman KW, Segelmark M.

Clin Exp Immunol. 1999 May;116(2):379-82.

9.

Persistent high prevalence of thyroid antibodies after immunosuppressive therapy in subjects with glomerulonephritis. A prospective three-year follow-up study.

Westman KW, Bygren PG, Ericsson UB, Høier-Madsen M, Wieslander J, Erfurth EM.

Am J Nephrol. 1998;18(4):274-9.

PMID:
9653829
10.
11.

Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody.

Westman KW, Selga D, Bygren P, Segelmark M, Baslund B, Wiik A, Wieslander J.

Kidney Int. 1998 May;53(5):1230-6.

12.

Prevalence of autoantibodies associated with glomerulonephritis, unaffected after extracorporeal shock wave lithotripsy for renal calculi, in a three-year follow-up.

Westman KW, Ericsson UB, Höier-Madsen M, Wieslander J, Lindstedt E, Bygren PG, Erfurth EM.

Scand J Urol Nephrol. 1997 Oct;31(5):463-7.

PMID:
9406309
13.

Rapid screening assay for anti-GBM antibody and ANCAs; an important tool for the differential diagnosis of pulmonary renal syndromes.

Westman KW, Bygren PG, Eilert I, Wiik A, Wieslander J.

Nephrol Dial Transplant. 1997 Sep;12(9):1863-8.

PMID:
9306336
14.

Increased prevalence of thyroid peroxidase antibodies (TPO-Ab) in women with glomerulonephritis.

Westman KW, Erfurth EM, Hagmar L, Bygren PG, Ericsson UB, Landin-Olsson M.

Nephrol Dial Transplant. 1993;8(5):402-6.

PMID:
8393543

Supplemental Content

Loading ...
Support Center